Interleukin-1β-induced expression of the urokinase-type plasminogen activator receptor and its co-localization with MMPs in human articular chondrocytes

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 105-112

  Schwab, W ^a   Schulze Tanzil, G ^b   Mobasheri, A ^c   Dressler, J ^d   Kotzsch, M ^d   Skakibaei, M ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Chondrocyte; IL 1 ; MMP 9; Osteoarthritis; uPAR

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; SERINE PROTEINASE; UROKINASE RECEPTOR; CELL SURFACE RECEPTOR; INTERLEUKIN 1; METALLOPROTEINASE; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; UROKINASE;

ARTICLE; ARTICULAR CARTILAGE; ASSAY; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; SERODIAGNOSIS; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; METALLOENDOPEPTIDASES; MICROSCOPY, IMMUNOELECTRON; PRECIPITIN TESTS; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 1642474409     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bechtel M.J., Reinartz J., Rox J.M., Inndorf S., Schaefer B.M. and Kramer M.D. (1996). Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha. Exp. Cell Res. 223, 395-404.
2. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F. and Dano K. (1991). The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem. 266, 7842-7847.
3. Blasi F. (1999). The urokinase receptor. A cell surface, regulated chemokine. APMIS 107, 96-101.
4. Bunning R.A., Crawford A, Richardson H.J., Opdenakker G., Van Damme J. and Russell R.G. (1987). Interleukin 1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes. Biochim. Biophys. Acta 924, 473-482.
5. Campbell I.K, Piccoli D.S, Butler D.M., Singleton D.K. and Hamilton J.A. (1988). Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim. Biophys. Acta 967, 183-194.
6. Chu T.M. and Kawinski E. (1998). Plasmin, substilisin-like endoproteinases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent are involved in activation of latent TGF-β 1 in human seminal plasma. Biochem. Biophys. Res. Commun. 253, 128-134.
7. Cook J.L, Anderson C.C, Kreeger J.M. and Tomlinson J.L. (2000). Effects of human recombinant interleukin-1β on canine articular chondrocytes in three-dimensional culture. Am. J. Vet. Res. 61, 766-770.
8. Del Rosso M, Fibbi G, Magnelli L, Pucci M, Dini G, Grappone C, Caldini R, Serni U, Colombo F. and Borella F. (1990). Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein. Int. J. Tissue React. 12, 91-100.
9. Del Rosso M, Fibbi G. and Matucci Cerinic M. (1999). The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin. Exp. Rheumatol. 17, 485-498.
10. Falcone D.J, McCaffrey T.A., Haimovitz-Friedman A, Vergilio J.A. and Nicholson A.C. (1993). Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J. Biol. Chem. 268, 11951-11958.
11. Fibbi G, Serni U, Matucci A, Mannoni A, Pucci M, Anichini E. and Del Rosso M. (1994). Control of the chondrocyte fibrinolytic balance by the drug piroxicam: Relevance to the osteoarthritic process. J. Rheumatol. 21, 2322-2328.
12. Fibbi G, Pucci M, Serni U, Cerinic MM. and Del Rosso M. (1998). Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro. Proc. Assoc. Am. Physicians 110, 340-350.
13. Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P., Nishiguchi T, Harbeck N, Kessler H, Luther T, Magdolen V. and Reuning U. (1998). Urokinase induces proliferation of human ovarian cancer cells: Characterization of structural elements required for growth factor function. FEBS Lett. 438, 101-105.
14. Goggs R, Carter S.D., Schulze-Tanzil G, Shakibaei M. and Mobasheri A. (2003). Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet. J. 166, 140-158.
15. Gowen M, Wood D.D., Ihrie E.J., Meats J.E. and Russell R.G. (1984). Stimulation by human interleukin-1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim. Biophys. Acta 797, 186-193.
16. Guo M, Mathieu P.A., Linebaugh B, Sloane B.F. and Reiners J.J. (2002). Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. J. Biol. Chem. 277, 14829-14837.
17. Hamilton J.A., Hart P.H, Leizer T, Vitti G.F. and Campbell I.K. (1991). Regulation of plasminogen activator activity in arthritic joints. J. Rheumatol. Suppl. 27, 106-109.
18. Hasegawa T, Sorensen L, Dohi M, Rao N.V., Hoidal J.R. and Marshall B.C. (1997). Induction of urokinase-type plasminogen activator receptor by IL-1β. Am. J. Respir. Cell Mol. Biol. 16, 683-692.
19. Herbert J.M., Lamarche I. and Carmeliet P. (1997). Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J. Biol. Chem. 272, 23585-23591.
20. Hurwitz A, Finci-Yeheskel Z, Dushnik M, Milwidsky A, Shimonovitz S, Yagel S, Adashi E.Y. and Mayer M. (1995). Interleukin-1-mediated regulation of plasminogen activation in pregnant mare serum gonadotropin-primed rat granulosa cells is independent of prostaglandin production. J. Soc. Gynecol. Invest. 2, 691-699.
21. Lund L.R, Ellis V., Ronne E, Pyke C. and Dano K. (1995). Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J. 310, 345-352.
22. Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H., Graeff H, Muller M. and Schmitt M. (1997). Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Am. J. Pathol. 150, 1231-1244.
23. Lyons R.M., Gentry L.E, Purchio A.F. and Moses H.L. (1990). Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110, 1361-1367.
24. Mankin H.J., Dorfman H, Lippiello L. and Zarins A. (1971). Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. Am. 53, 523-537.
25. Martel-Pelletier J, Faure M.P., McCollum R., Mineau F., Cloutier J.M. and Pelletier J.P. (1991). Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J. Rheumatol. 18, 1863-1871.
26. Martel-Pelletier J. (1998). Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 6, 374-376.
27. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S. and Mignatti P. (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J. 16, 2319-2332.
28. Nykjaer A, Petersen C.M, Moller B, Jensen P.H., Moestrup S.K., Holtet T.L., Etzerodt M, Thogersen H.C., Munch M., Andreasen P.A. and Gliemann J. (1992). Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase, plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543-14546.
29. Ogura N, Nagura H. and Abiko Y. (1999). Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblast by Porphyromonas gingivalis lipopolysaccharide. J. Periodontol. 70, 402-408.
30. Olesksyszyn J. and Augustine A.J. (1996). Plasminogen modulation of IL-1β-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors. PAI-1, α2-antiplasmin, α1-PI, α2-macroglobulin and TIMP. Inflamm. Res. 45, 464-472.
31. Pedrozo H.A, Schwartz Z, Robinson M, Gomes R, Dean D.D., Bonewald L.F. and Boyan B.D. (1999). Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor β1 from the extracellular matrix of growth plate chondrocytes. Endocrinology 140, 5806-5816.
32. Ploug M. and Ellis V. (1994). Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett. 349, 163-168.
33. Preissner K.T., Kanse S.M. and May A.E. (2000). Urokinase receptor: A molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628.
34. Robbins JR, Thomas B, Tan L, Choy B, Arbiser J.L, Berenbaum F, and Goldring M.B. (2000). Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1β. Arthritis Rheum. 43, 2189-2201.
35. Saito S, Katoh M, Masumoto M, Matsumoto S. and Masuho Y. (1998). Involvement of MMP-1 and MMP-3 in collagen degradation induced by IL-1β in rabbit cartilage explant culture. Life Sci. 62, 359-365.
36. Saksela O. and Rifkin D.B. (1988). Cell-associated plasminogen activation: Regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
37. Schulze-Tanzil G., De Souza P., Merker H.-J. and Shakibaei M. (2001). Co-localization of integrins and matrix metalloproteinases in the extracellular matrix of chondrocyte cultures. Histol. Histopathol. 16, 1081-1089.
38. Schulze-Tanzil G., De Souza P., Behnke B., Klingelhoefer S., Scheid A. and Shakibaei M. (2002). Effects of the antirheumatic remedy Hox alpha - A new stinging nettle leaf extract - On matrix metalloproteinases in human chondrocytes in vitro. Histol. Histopathol. 17, 477-485.
39. Schwab W., Gavlik J.M., Beichler T., Funk R.H., Albrecht S., Magdolen V., Luther T., Kasper M. and Shakibaei M. (2001). Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: Association with caveolin and β1-integrin. Histochem. Cell Biol. 115, 317-323.
40. Serni U., Fibbi G., Anichini E., Zamperni A., Pucci M., Mannoni A., Matucci A., Benucci M., Del Rosso A. and Del Rosso M. (1995). Plasminogen activator and receptor in osteoarthritis. J. Rheumatol. Suppl. 43, 120-122.
41. Shakibaei M. and Merker H.-J. (1999). β1-integrins in the cartilage matrix. Cell Tissue Res. 296, 565-573.
42. Shakibaei M., Zimmermann B. and Scheller M. (1993). Endocytosis of integrin α5, 1 (fibronectin receptor) of mouse peritoneal macrophages in vitro: An immunoelectron microscopic study. J. Struct. Biol. 111, 180-189
43. Shakibaei M., John T., De Souza P., Rahmanzadeh R. and Merker H.J. (1999). Signal transduction by β1-integrin receptors in human chondrocytes in vitro: Collaboration with the insulin-like growth factor-I receptor. Biochem. J. 342, 615-623.
44. Shetty S., Kumar A., Johnson A.R., Pueblitz S., Holiday D., Raghu G. and Idell S. (1996). Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am. J. Respir. Cell Mol. Biol. 15, 78-87.
45. Siren V., Myohanen H., Vaheri A. and Immonen I. (1999). Transforming growth factor β induces urokinase receptor expression in cultured retinal pigment epithelial cells. Ophthalmic. Res. 31, 184-191.
46. Syrovets T., Jendrach M., Rohwedder A., Schüle A. and Simmet T. (2001). Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKβ-mediated NF-κβ activation. Blood 97, 3941-3950.
47. Tran-Thang C., Kruithof E., Lahm H., Schuster W.A., Tada M. and Sordat B. (1996). Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br. J. Cancer 74, 846-852.
48. Vincenti M.P. and Brinckerhoff C.E. (2001). Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1β. Arthritis Res. 3, 381-388.
49. Walter H., Kawashima A., Nebelung W., Neumann W. and Roessner A. (1998). Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol. Res. Pract. 194, 73-81.
50. Waltz D.A., Sailor L.Z. and Chapman H.A. (1993). Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91, 1541-1552.
51. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S. and Chapman H.A. (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269, 32380-32388.
52. Wu S., Murrell G.A. and Wang Y. (2002). Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression. Cancer Immunol. Immunother. 51, 248-254.